The Biomarkers Market Size is projected to grow from USD 67.92 billion in 2023 to USD 184.80 billion
This report emphasizes the increasing prevalence and incidence of diseases that need biomarker-based diagnosis, leading to greater demand for precision medicine and targeted treatments. The research looks at biomarker testing volume and adoption patterns across geographies, indicating the increased dependence on early disease detection and personalized treatment strategies. It also discusses advances in biomarker-based diagnostics and drug development, highlighting advances in liquid biopsy, companion diagnostics, and AI-assisted analysis. The study also evaluates healthcare expenditure on biomarker-based treatments and diagnostics across regions, highlighting the role of research investments, government programs, and changing reimbursement policies in propelling market growth.